Epizyme, Inc. SEC Filings

Filed On	Filing
14 Feb 2023	SC 13G/A
08 Sep 2022	PRIMECAP MANAGEMENT CO/CA/
23 Aug 2022	15-12G
16 Aug 2022	EFFECT
16 Aug 2022	EFFECT
16 Aug 2022	EFFECT
16 Aug 2022	Form 4: Giordano Michael F, Director Returned 17,054 shares to the issuer
16 Aug 2022	Form 4: Goldfischer Carl, Director Returned 3,403,005 shares to the issuer
16 Aug 2022	Form 4: Conroy Kevin T, Director Returned 62,318 shares to the issuer
16 Aug 2022	Form 4: Richon Victoria, Director Returned 22,608 shares to the issuer
16 Aug 2022	Form 4: Mott David M, Director Disposed of 322,453 shares (Tender Offer) · Returned 8,994 shares to the issuer
16 Aug 2022	Form 4: BEVERIDGE, Roy A, Director Returned 46,037 shares to the issuer
16 Aug 2022	Form 4: Agarwal Shefali, See Remarks Returned 286,539 shares to the issuer
16 Aug 2022	Form 4: Korn Jerald, Chief Operating Officer
16 Aug 2022	Form 4: Legorreta Pablo G., Director and 3 others Disposed of 31,933,334 shares (Tender Offer) · Disposed of 17,054 Restricted Stock Units (Disposition to Issuer)
16 Aug 2022	Form 4: Beaulieu Joseph, See Remarks Returned 52,076 shares to the issuer
16 Aug 2022	Form 4: Bate Kenneth, Director Returned 17,054 shares to the issuer
16 Aug 2022	Form 4: Kutok Jeffery, Chief Scientific Officer Returned 120,067 shares to the issuer
16 Aug 2022	Form 4: Stuckley Carol, Director Returned 25,696 shares to the issuer
16 Aug 2022	Form 4: Bogle Grant C., Director Returned 259,170 shares to the issuer

Comments